Sotatercept May Have Long Term Benefit in Pulmonary Arterial Hypertension
Is sotatercept safe and effective for pulmonary arterial hypertension over 18 to 24 months of use? Results of the PULSAR open label-extension trial address this question.
Pulmonary Hypertension
Pulmonary Arterial Hypertension Studies Need to Consider Sex-Based Differences
In studies of pulmonary arterial hypertension, to what extent does sex/gender affect baseline values for measures such as 6MWD, hemodynamics, and functional class?
OSA Is Prevalent in Pulmonary Hypertension, Especially in WHO Group II PH
How prevalent is OSA among those with pulmonary hypertension, and does the prevalence and severity vary between different the 5 World Health Organization PH groups?
A Comparison of Balloon Pulmonary Angioplasty vs Riociguat for Inoperable CTEPH
Which therapy more effectively treats inoperable chronic thromboembolic pulmonary hypertension, riociguat or balloon pulmonary angioplasty — and which is safer?
Mortality and Thyroid-Stimulating Hormone in Pulmonary Arterial Hypertension
Is mortality from PAH linked to thyroid dysfunction? To explore this, researchers measured thyroid stimulating hormone levels in patients with PAH.
Nomogram Predicts OSA in Patients With Pulmonary Arterial Hypertension
A newly developed nomogram for predicting OSA in patients with PAH may facilitate early identification and treatment of OSA in these patients.
Higher Right Ventricular Afterload in Older Adults Linked to Greater Risk for AF
Researchers sought to determine the relationship between increased right ventricular afterload and risk for atrial fibrillation.
Is Conduction Disease More Prevalent in Idiopathic Pulmonary Hypertension?
How prevalent is disordered cardiac conduction in patients with IPAH, and how does the condition affect patient functioning and prognosis?
CTEPH Diagnosis Is Often Missed Post PE, Retrospective Study Confirms
A study of patient follow-up trajectories following acute pulmonary embolism found missed opportunities for diagnosing CTEPH.
Percutaneous Transluminal Pulmonary Angioplasty for Takayasu Arteritis-Associated Pulmonary HTN
Researchers sought to determine the efficacy and safety of percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary HTN.
- Loading...
Loading...
Next post in Pulmonary Hypertension
Loading... 
Loading...